You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
力生製藥(002393.SH):非布司他原料藥通過上市申請
格隆匯 06-14 15:52

格隆匯6月14日丨力生製藥(002393.SH)公佈,收到國家藥品監督管理局頒發的關於非布司他原料藥《化學原料藥上市申請批准通知書》,該品種通過化學原料藥上市申請。

非布司他為2-芳基噻唑衍生物,是一種黃嘌呤氧化酶抑制劑,可以通過抑制尿酸合成、促進尿酸排泄,起到降低血清尿酸濃度的作用,適用於痛風患者高尿酸血癥的長期治療,不推薦用於無臨牀症狀的高尿酸血癥,其常規治療濃度下不會抑制其他參與嘌呤和嘧啶合成與代謝的酶。臨牀研究顯示,非布司他片治療痛風伴高尿酸血癥患者,安全且高效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account